Login

Arjan Meijer Discusses New Embraer Turboprop | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
American Eagle Gold Reports Exciting New Drilling Results and Expands Exploration Program
00:10:00
Bill Demchak's Economic Outlook: Market Resilience Amid Uncertainty | Bill Demchak, CEO, PNC Financial Services .
00:10:00
Birimian Lithium Project Financing Strategy
00:10:00
Redefining Energy: How Commodities, Branding, and Financing are Driving the Green Transition
00:10:00
Air Partner (AIR) interim results interview with CEO Mark Briffa and ContextVision AB's 2023 year-end report highlight underlying growth.|Gerald Pötzsch joined ContextVision in August 2022 as CEO.
00:10:00
Q3 2014 Market Update: Navigating Volatility and Economic Resilience
00:10:00
Excelsior Mining's Stephen Twyerould Discusses Gunnison Copper Project at Vancouver Conference
00:00:00
AirXpanders Inc.(ASX:AXP) sales and product update - Scott Dodson, CEO,AirXpanders Inc
00:10:00
TD Ameritrade to Schwab Q3 Transition: Scam Alert | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
EY and CrowdStrike Alliance for Digital Transformation | Carmine Di Sibio, CEO , Ernst & Young.
00:10:00
John F. Layman's Journey: From Political Science to National Security Leadership
00:10:00
Trilogy Metals: Advancing High-Grade Copper Projects in Alaska with Key Developments and Strategic Partnerships

© 2017 - Neuhu+